# Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

> **NCT07287163** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Praxis Precision Medicines** · enrollment: 700 (estimated)

## Conditions studied

- Epilepsy, Tonic-Clonic
- Focal Seizure
- Primary Generalized Seizure

## Interventions

- **DRUG:** vormatrogine

## Key facts

- **NCT ID:** NCT07287163
- **Lead sponsor:** Praxis Precision Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-10-27
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07287163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07287163, "Clinical Trial of Vormatrigine in Adult Patients With Epilepsy". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07287163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*